PatientsVille.com Logo

PatientsVille

Amoksiklav Side Effects

Common Amoksiklav Side Effects


The most commonly reported Amoksiklav side effects (click to view or check a box to report):

Dyspnoea (6)
Rash (4)
Pruritus (4)
Urticaria (3)
Blood Pressure Decreased (3)
Abdominal Pain (2)
Heart Rate Increased (2)
Hyperthermia (2)
Chills (2)
Hypoaesthesia (2)
Bile Duct Obstruction (2)
Back Pain (2)
Purpura (2)
Joint Swelling (2)
Jaundice Cholestatic (2)
Loss Of Consciousness (2)
Petechiae (2)
Syncope (2)
Rash Pustular (2)
Weight Decreased (2)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Amoksiklav Side Effects Reported to FDA

The following Amoksiklav reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Amoksiklav on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Angioedema, Face Oedema, Dyspnoea
This is a report of a 27-year-old female patient (weight: NA) from PL, suffering from the following symptoms/conditions: NA, who was treated with Amoksiklav (dosage: 1 G, Qd, start time: Mar 27, 2013), combined with: NA. and developed a serious reaction and side effect(s). The consumer presented with:
  • Angioedema
  • Face Oedema
  • Dyspnoea
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Amoksiklav treatment in female patients, resulting in angioedema side effect. The patient was hospitalized.

Dyspnoea, Urticaria
This report suggests a potential Amoksiklav Dyspnoea, Urticaria side effect(s) that can have serious consequences. A 37-year-old female patient (weight: NA) from PL was diagnosed with the following symptoms/conditions: pharyngitis and used Amoksiklav (dosage: 1000 Mg, Bid) starting Feb 07, 2013. Soon after starting Amoksiklav the patient began experiencing various side effects, including:
  • Dyspnoea
  • Urticaria
Drugs used concurrently:
  • Chlorchinaldin
  • Pyralgin
  • Herbapect
The patient was hospitalized. Although Amoksiklav demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as dyspnoea, may still occur.

Aphthous Stomatitis, Fatigue, Abdominal Pain Upper, Epigastric Discomfort, Dysgeusia, Oedema Mouth
This Aphthous Stomatitis, Fatigue, Abdominal Pain Upper, Epigastric Discomfort, Dysgeusia, Oedema Mouth problem was reported by a health professional from SK. A 62-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: bronchitis. On Apr 23, 2013 this consumer started treatment with Amoksiklav (dosage: 1 G, Bid). The following drugs were being taken at the same time:
  • Betaloc Zok
  • Atoris
  • Norvasc
  • Lexaurin
When commencing Amoksiklav, the patient experienced the following unwanted symptoms/side effects:
  • Aphthous Stomatitis
  • Fatigue
  • Abdominal Pain Upper
  • Epigastric Discomfort
  • Dysgeusia
  • Oedema Mouth
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as aphthous stomatitis, may become evident only after a product is in use by the general population.

Melaena, Asthenia, Decreased Appetite, Faeces Discoloured, Diarrhoea
This is a report of a 82-year-old male patient (weight: NA) from RU. The patient developed the following symptoms/conditions: respiratory disorder and was treated with Amoksiklav (dosage: 625 Mg, Bid) starting Mar 06, 2013. Concurrently used drugs:
  • Linex
  • Grammidin
Soon after that, the consumer experienced the following side effects:
  • Melaena
  • Asthenia
  • Decreased Appetite
  • Faeces Discoloured
  • Diarrhoea
This opens a possibility that Amoksiklav treatment could cause the above reactions, including melaena, and some male subjects may be more susceptible.


Nausea, Visual Impairment, Loss Of Consciousness, Abdominal Pain, Blood Pressure Decreased
A 54-year-old female patient (weight: NA) from PL with the following symptoms/conditions: acute sinusitis started Amoksiklav treatment (dosage: 1.2 G, Bid) on Jan 26, 2013. Soon after starting Amoksiklav treatment, the subject experienced various side effects, including:
  • Nausea
  • Visual Impairment
  • Loss Of Consciousness
  • Abdominal Pain
  • Blood Pressure Decreased
Concurrently used drugs:
  • Dexaven (8 Mg,)
  • Ortanol (40 Mg, Bid)
  • Zinacef (1500 Mg, Bid)
The patient was hospitalized. This finding indicates that some female patients could be more vulnerable to Amoksiklav.


A 18-year-old male patient from RU (weight: NA) experienced symptoms, such as: respiratory disorder and was treated with Amoksiklav(dosage: 625 Mg, Qd). The treatment was initiated on Nov 27, 2012. After that a consumer reported the following side effect(s):
    Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Amoksiklav efficacy:
    • Arbidol
    • Analgin
    • Septolete


    Pyothorax
    In this report, Amoksiklav was administered for the following condition: pneumonia.A 40-year-old male consumer from RUSSIAN FEDERATION (weight: NA) started Amoksiklav treatment (dosage: Unk) on Jan 15, 2011.Sometime after starting the treatment, the patient complained of the following side effect(s):
    • Pyothorax
    A possible interaction with other drugs could have contributed to this reaction:
    • Moxifloxacin (400 Mg, Qd)
    • Sumamed (Unk)
    • Claforan (Unk)
    • Ambroxol (120 Mg, Qd)
    • Heparin (10000 Iu, Qd)
    • Avelox (400 Mg, Qd)
    • Sulperason (4 G, Qd)
    • Ketonal (2 /ml, Qd)
    The patient was hospitalized.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Amoksiklav treatment could be related to the listed above side effect(s).

    Dyspnoea, Dysphonia, Pruritus, Rash
    This is a report of the following Amoksiklav side effect(s):
    • Dyspnoea
    • Dysphonia
    • Pruritus
    • Rash
    A 40-year-old female patient from RUSSIAN FEDERATION (weight: NA) presented with the following condition: NA and received a treatment with Amoksiklav (dosage: Unk) starting: NS.The following concurrently used drugs could have generated interactions: NA.This report suggests that a Amoksiklav treatment could be associated with the listed above side effect(s).

    Back Pain, Blood Pressure Decreased, Chills, Heart Rate Increased, Hyperthermia
    This Amoksiklav (ngx) report was submitted by a 27-year-old female consumer from RUSSIAN FEDERATION (weight: NA). The patient was diagnosed with: pyelonephritis chronic and Amoksiklav (ngx) was administered (dosage: 1200 Mg, Daily) starting: Jun 12, 2010. The consumer developed a set of symptoms:
    • Back Pain
    • Blood Pressure Decreased
    • Chills
    • Heart Rate Increased
    • Hyperthermia
    Other drugs used simultaneously:
    • Sodium Chloride (Unk)
    Those unexpected symptoms could be linked to a Amoksiklav (ngx) treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

    Back Pain, Blood Pressure Decreased, Chills, Heart Rate Increased, Hyperthermia
    This is a report of a possible correlation between Amoksiklav (ngx) use and the following symptoms/side effect(s):
    • Back Pain
    • Blood Pressure Decreased
    • Chills
    • Heart Rate Increased
    • Hyperthermia
    which could contribute to an assessment of Amoksiklav (ngx) risk profile.A 27-year-old female consumer from RUSSIAN FEDERATION (weight: NA) was suffering from pyelonephritis chronic and was treated with Amoksiklav (ngx) (dosage: 1200 Mg, Daily) starting Jun 12, 2010.Other concurrent medications:
    • Sodium Chloride (Unk)


    Cyanosis, Dyspnoea, Hypoaesthesia, Rash Pustular, Syncope
    A 27-year-old female patient from POLAND (weight: NA) presented with the following symptoms: upper respiratory tract infection and after a treatment with Amoksiklav (ngx) (dosage: 1000 Mg/day) experienced the following side effect(s):
    • Cyanosis
    • Dyspnoea
    • Hypoaesthesia
    • Rash Pustular
    • Syncope
    The treatment was started on Oct 05, 2009. Amoksiklav (ngx) was used in combination with the following drugs:
    • Atarax
    The patient was hospitalized.This report could alert potential Amoksiklav (ngx) consumers.

    Cyanosis, Dyspnoea, Hypoaesthesia, Rash Pustular, Syncope
    In this report, a 27-year-old female patient from POLAND (weight: NA) was affected by a possible Amoksiklav (ngx) side effect.The patient was diagnosed with upper respiratory tract infection. After a treatment with Amoksiklav (ngx) (dosage: 1000 Mg/day, start date: Oct 05, 2009), the patient experienced the following side effect(s):
    • Cyanosis
    • Dyspnoea
    • Hypoaesthesia
    • Rash Pustular
    • Syncope
    The following simultaneously used drugs could have led to this reaction: NA.The patient was hospitalized.The findings here stress that side effects should be taken into consideration when evaluating a Amoksiklav (ngx) treatment.

    Blood Bilirubin Increased, Erythema, Gamma-glutamyltransferase, Gastrointestinal Haemorrhage, Hepatic Enzyme Increased, Hypotension, Pruritus, Rash
    This is a report of a 71-year-old male patient from POLAND (weight: NA), who used Amoksiklav (ngx) (amoxicillin, Clavulanate) Powder For Sol For Inf (dosage: 1200 Mg, Intravenous) for a treatment of pyrexia. After starting a treatment on May 21, 2008, the patient experienced the following side effect(s):
    • Blood Bilirubin Increased
    • Erythema
    • Gamma-glutamyltransferase
    • Gastrointestinal Haemorrhage
    • Hepatic Enzyme Increased
    • Hypotension
    • Pruritus
    • Rash
    The following drugs could possibly have interacted with the Amoksiklav (ngx) (amoxicillin, Clavulanate) Powder For Sol For Inf treatment NA.Taken together, these observations suggest that a Amoksiklav (ngx) (amoxicillin, Clavulanate) Powder For Sol For Inf treatment could be related to side effect(s), such as Blood Bilirubin Increased, Erythema, Gamma-glutamyltransferase, Gastrointestinal Haemorrhage, Hepatic Enzyme Increased, Hypotension, Pruritus, Rash.

    Dyspnoea, Rash Maculo-papular
    This dyspnoea side effect was reported by a consumer or non-health professional from POLAND. A 64-year-old male patient (weight:NA) experienced the following symptoms/conditions: laryngitis. The patient was prescribed Amoksiklav (ngx) (amoxicillin, Clavulanate) Tablet, 625mg (dosage: 625 Mg, Bid, Oral), which was started on Jan 03, 2008. Concurrently used drugs:
    • Acetylcysteine
    When starting to take Amoksiklav (ngx) (amoxicillin, Clavulanate) Tablet, 625mg the consumer reported the following symptoms:
    • Dyspnoea
    • Rash Maculo-papular
    The patient was hospitalized. These side effects may potentially be related to Amoksiklav (ngx) (amoxicillin, Clavulanate) Tablet, 625mg.

    Pruritus
    This is a Amoksiklav (ngx)(amoxicillin, Clavulanate) Tablet, 625mg side effect report of a 56-year-old male patient (weight:NA) from POLAND, suffering from the following symptoms/conditions: urethritis, who was treated with Amoksiklav (ngx)(amoxicillin, Clavulanate) Tablet, 625mg (dosage:625 Mg, Tid, Oral, start time: Jun 04, 2007), combined with: NA., and developed a serious reaction and a pruritus side effect. The patient presented with:
    • Pruritus
    which developed after the beginning of treatment. The patient was hospitalized. This side effect report can indicate a possible existence of increased vulnerability to Amoksiklav (ngx)(amoxicillin, Clavulanate) Tablet, 625mg treatment in male patients suffering from urethritis, resulting in pruritus.

    Excoriation, Petechiae, Pruritus, Rash Macular
    This report suggests a potential Amoksiklav (ngx) (amoxicillin, Clavulanate) Tablet, 625mg excoriation side effect(s) that can have serious consequences. A 6-year-old male patient from POLAND (weight:NA) was diagnosed with the following health condition(s): upper respiratory tract infection and used Amoksiklav (ngx) (amoxicillin, Clavulanate) Tablet, 625mg (dosage: 625 Mg, Bid, Oral) starting Dec 27, 2006. Soon after starting Amoksiklav (ngx) (amoxicillin, Clavulanate) Tablet, 625mg the patient began experiencing various side effects, including:
    • Excoriation
    • Petechiae
    • Pruritus
    • Rash Macular
    Drugs used concurrently:NA. Although Amoksiklav (ngx) (amoxicillin, Clavulanate) Tablet, 625mg demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as excoriation, may still occur.

    Febrile Convulsion
    This febrile convulsion problem was reported by a physician from POLAND. A 2-year-old female patient (weight: NA) was diagnosed with the following medical condition(s): rhinitis.On Apr 10, 2006 a consumer started treatment with Amoksiklav (ngx) (amoxicillin, Clavulanate) Suspension (dosage: 3 Ml, Bid, Oral). The following drugs/medications were being taken at the same time:
    • Probiolac (lactobacillus Acidophilus)
    • Pyrosal
    • Clemastine
    • Acetaminophen
    When commencing Amoksiklav (ngx) (amoxicillin, Clavulanate) Suspension, the patient experienced the following unwanted symptoms /side effects:
    • Febrile Convulsion
    Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as febrile convulsion, may become evident only after a product is in use by the general population.

    Bile Duct Obstruction, Dyspepsia, Gastritis, Hepatic Failure, Jaundice Cholestatic, Weight Decreased
    This is a Amoksiklav side effect report of a 12-year-old female patient (weight: NA) from POLAND. The patient developed the following symptoms/conditions: upper respiratory tract infection and was treated with Amoksiklav (dosage: Oral) starting Nov 01, 2005. Concurrently used drugs: NA. Soon after that, the consumer experienced the following of symptoms:
    • Bile Duct Obstruction
    • Dyspepsia
    • Gastritis
    • Hepatic Failure
    • Jaundice Cholestatic
    • Weight Decreased
    The patient was hospitalized. This opens a possibility that Amoksiklav could cause bile duct obstruction and that some female patients may be more susceptible.

    Abdominal Pain, Bile Duct Obstruction, Dyspepsia, Gastritis, Gastrooesophageal Reflux Disease, Jaundice Cholestatic, Vomiting, Weight Decreased
    A 12-year-old female patient (weight: NA) from POLAND with the following symptoms: upper respiratory tract infection started Amoksiklav (ngx) (amoxicillin, Clavulanate) treatment (dosage: Oral) on Nov 01, 2005. Soon after starting Amoksiklav (ngx) (amoxicillin, Clavulanate) treatment, the consumer experienced several side effects, including:
    • Abdominal Pain
    • Bile Duct Obstruction
    • Dyspepsia
    • Gastritis
    • Gastrooesophageal Reflux Disease
    • Jaundice Cholestatic
    • Vomiting
    • Weight Decreased
    . Concurrently used drugs: NA.The patient was hospitalized. This finding indicates that some patients can be more vulnerable to developing Amoksiklav (ngx) (amoxicillin, Clavulanate) side effects, such as abdominal pain.

    Joint Swelling, Urticaria
    This joint swelling side effect was reported by a physician from POLAND. A 2-year-old male patient (weight:NA) experienced the following symptoms/conditions: pneumonia.The patient was prescribed Amoksiklav (ngx) (amoxicillin, Clavulanate)suspension, 457 Mg/5ml (dosage: 10 Ml 914 Mg), Oral), which was started on Sep 22, 2005. Concurrently used drugs: NA..When starting to take Amoksiklav (ngx) (amoxicillin, Clavulanate)suspension, 457 Mg/5ml the consumer reported symptoms, such as:
    • Joint Swelling
    • Urticaria
    These side effects may potentially be related to Amoksiklav (ngx) (amoxicillin, Clavulanate)suspension, 457 Mg/5ml. The patient was hospitalized.

    Joint Swelling, Petechiae, Urticaria
    This is a report of a 4-year-old male patient (weight: NA) from POLAND, suffering from the following symptoms/conditions: pharyngitis, who was treated with Amoksiklav (ngx) (amoxicillin, Clavulanate)suspension, 457mg/5ml (dosage: 10 Ml (914 Mg), Oral, start time: Sep 22, 2005), combined with: NA. and developed a serious reaction and side effect(s). The consumer presented with:
    • Joint Swelling
    • Petechiae
    • Urticaria
    which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Amoksiklav (ngx) (amoxicillin, Clavulanate)suspension, 457mg/5ml treatment in male patients, resulting in joint swelling side effect. The patient was hospitalized.

    Anaphylactic Shock, Loss Of Consciousness
    This report suggests a potential Amoksiklav Anaphylactic Shock, Loss Of Consciousness side effect(s) that can have serious consequences. A 5-year-old female patient (weight: NA) from POLAND was diagnosed with the following symptoms/conditions: prophylaxis and used Amoksiklav (dosage: See Image) starting NS. Soon after starting Amoksiklav the patient began experiencing various side effects, including:
    • Anaphylactic Shock
    • Loss Of Consciousness
    Drugs used concurrently:
    • Solu-medrol
    • Ranigast (ranitidine Hydrochloride)
    Although Amoksiklav demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as anaphylactic shock, may still occur.

    Cardiac Arrest, Feeling Abnormal
    This Cardiac Arrest, Feeling Abnormal problem was reported by a physician from . A 29-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: infection. On NS this consumer started treatment with Amoksiklav (ngx) (amoxicillin, Clavulanate) Tablet, 1000mg (dosage: Oral). The following drugs were being taken at the same time:
    • Rulid (roxithromycin)
    • Lamotrigine
    When commencing Amoksiklav (ngx) (amoxicillin, Clavulanate) Tablet, 1000mg, the patient experienced the following unwanted symptoms/side effects:
    • Cardiac Arrest
    • Feeling Abnormal
    Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as cardiac arrest, may become evident only after a product is in use by the general population.

    Exanthem, Purpura, Rash
    This is a report of a 76-year-old male patient (weight: NA) from . The patient developed the following symptoms/conditions: ear infection and was treated with Amoksiklav (ngx) (amoxicillin, Clavulanate) Tablet, 1g (dosage: 1 G, Bid, Oral) starting Dec 02, 2004. Concurrently used drugs:
    • Vessel Due F (sulodexide)
    • Trental (pentoxiflylline)
    • Agen (amlodipine Besilate)
    • Tenoloc (celiprolol Hydrochloride)
    • Secatoxin (dihydroergotoxine Mesilate)
    Soon after that, the consumer experienced the following side effects:
    • Exanthem
    • Purpura
    • Rash
    The patient was hospitalized. This opens a possibility that Amoksiklav (ngx) (amoxicillin, Clavulanate) Tablet, 1g treatment could cause the above reactions, including exanthem, and some male subjects may be more susceptible.

    Exanthem, Purpura, Rash
    A 76-year-old male patient (weight: NA) from with the following symptoms/conditions: ear infection started Amoksiklav (ngx) (amoxicillin, Clavulanate) Tablet, 1g treatment (dosage: 1 G, Bid, Oral) on Dec 02, 2004. Soon after starting Amoksiklav (ngx) (amoxicillin, Clavulanate) Tablet, 1g treatment, the subject experienced various side effects, including:
    • Exanthem
    • Purpura
    • Rash
    Concurrently used drugs:
    • Vessel Due F (sulodexide)
    • Trental
    • Agen (amlodipine Besilate)
    • Tenoloc (celiprolol Hydrochloride)
    • Secatoxin (dihyroergotoxine Mesilate)
    The patient was hospitalized. This finding indicates that some male patients could be more vulnerable to Amoksiklav (ngx) (amoxicillin, Clavulanate) Tablet, 1g.



    Top 10 Amoksiklav Side Effects for Women

    Women Side EffectsReports
    Dyspnoea 5
    Blood Pressure Decreased 3
    Abdominal Pain 2
    Back Pain 2
    Bile Duct Obstruction 2
    Chills 2
    Cyanosis 2
    Dyspepsia 2
    Gastritis 2
    Heart Rate Increased 2

    Top 10 Amoksiklav Side Effects for Men

    Men Side EffectsReports
    Pruritus 3
    Rash 3
    Exanthem 2
    Joint Swelling 2
    Petechiae 2
    Purpura 2
    Urticaria 2
    Asthenia 1
    Blood Bilirubin Increased 1
    Death 1

    Keep Track of Side Effects

    Note Your Observations

    It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

    Why Your Notes are Important

    Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Amoksiklav Side Effects

    Did You Have a Amoksiklav Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Amoksiklav for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Amoksiklav Safety Alerts, Active Ingredients, Usage Information

    More About Amoksiklav

    Side Effects reported to FDA: 25

    Amoksiklav safety alerts: No

    Reported deaths: 1

    Reported hospitalizations: 5

    Latest Amoksiklav clinical trials